Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature
Epilepsia Open · 2026
DOI: 10.1002/epi4.70233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsia Open, 2026. Verfasst von Janina Gburek-Augustat und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, University Hospital for Children, Leipzig, Germany. Hauptthemen laut MEDLINE: Mucolipidoses, Anticonvulsants, Epilepsies, Myoclonic. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Sialidosis type I (ST‐1) is an autosomal‐recessive, very rare, progressive lysosomal storage disorder caused by pathogenic variants in NEU1 . It is clinically characterized by progressive ataxia, myoclonic seizures (MS), bilateral tonic–clonic seizures (BTCS), and distinctive ophthalmological findings. Given the lack of curative options, in this study, we investigated symptomatic treatment strategies, with a particular focus on the efficacy of antiseizure medications (ASMs).
Methods
We describe the clinical course of a patient followed from diagnosis to 18 years of age, and review seven additional cases from our cohort. In parallel, we conducted a narrative review of the literature (PubMed, January 2010–September 2025) to identify published reports containing therapeutic data.
Results
Therapeutic responses were evaluated in a total of 33 cases (8 from our cohort, 25 from published sources). Although available data are insufficient to define standardized treatment guidelines, some ASMs, such as ACZ, PER, LEV, VPA, CZP, and ZNS, demonstrated fairly consistent efficacy in managing MS and BTCS. Sodium oxybate or deep‐brain stimulation may be considered in refractory cases. Significance Prospective documentation of clinical course and treatment outcomes—ideally through an international registry—is crucial to improve patient care and inform therapeutic strategies. Plain Language Summary Sialidosis type I (ST‐1) is a very rare genetic disorder causing movement problems and seizures, with no cure available yet. We followed 8 patients and reviewed 25 published cases to assess treatments focusing on myoclonic seizure (MS) control. Some antiseizure medications showed benefit. However, we have too little data to make clear recommendations. To improve patients' treatment and to choose the most appropriate therapy, it would be important to follow patients over a longer period of time, for example, in an international registry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Neurology, University Hospital for Children, Leipzig, Germany.
- Department of Pediatrics, Taichung Tzu chi General Hospital, Taichung, Taiwan.
- Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
- Acibadem Labgen Genetic Diagnosis Center, Istanbul, Türkiye.
- Pediatric Epilepsy Clinic-Hospital Civil de Guadalajara, Guadalajara, Mexico.
- Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington, University School of Medicine, St. Louis, Missouri, USA.
ORCID-Profile: Janina Gburek-Augustat, Melissa Chavez-Castillo, Antonietta Coppola
Zitieren
APA
Gburek-Augustat, J., Lee, I. C., Rubino, M., Topçu, V., Chavez-Castillo, M., Tu, S. C., Shinawi, M., Alfradique-Dunham, I., Valtcheva, M., Adarmes-Gómez, A., Macias-Garcia, D., Laura Muñoz-Delgado, L., Jesús, S., Mir, P., Merkenschlager, A., & Coppola, A. (2026). Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature. Epilepsia Open. https://doi.org/10.1002/epi4.70233
Vancouver
Gburek-Augustat J, Lee IC, Rubino M, Topçu V, Chavez-Castillo M, Tu SC, et al. Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature. Epilepsia Open. 2026. doi:10.1002/epi4.70233
BibTeX
@article{GburekAugustat2026,
author = {Gburek-Augustat, Janina and Lee, I-Chun and Rubino, Marica and Topçu, Vehap and Chavez-Castillo, Melissa and Tu, Shao Ching and Shinawi, Marwan and Alfradique-Dunham, Isabel and Valtcheva, Manouela and Adarmes-Gómez, Astrid and Macias-Garcia, Daniel and Laura Muñoz-Delgado, Laura and Jesús, Silvia and Mir, Pablo and Merkenschlager, Andreas and Coppola, Antonietta},
title = {Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature},
journal = {Epilepsia Open},
year = {2026},
doi = {10.1002/epi4.70233}
}
EUVIMED